Judge Brian M. Cogan said in his ruling Tuesday that Curaleaf “publicly and repeatedly acknowledged” in its stock listing statement that the FDA had not yet approved its CBD products for any medical purpose.
JUDGEMENT
123117438266
Also see
Cogan_Oct-Nov2014_3-pgs-pdf-3